William Blair Reiterates Outperform Rating on Entrada Therapeutics (TRDA)

Go back to William Blair Reiterates Outperform Rating on Entrada Therapeutics (TRDA)
(NASDAQ: TRDA) Delayed: 6.79 +0.02 (0.30%)
Previous Close $6.77    52 Week High
Open $6.71    52 Week Low
Day High $6.90    P/E N/A 
Day Low $6.49    EPS
Volume 352,598